Lauxera Capital Partners has led a £25m growth investment into OrganOx, a commercial-stage, Oxford, England-based medical device company. OrganOx develops and commercializes organ preservation and
July 17, 2023
A Digital Publication for the Practicing Medical Specialist, Industry Executive, & Investor
Lauxera Capital Partners has led a £25m growth investment into OrganOx, a commercial-stage, Oxford, England-based medical device company. OrganOx develops and commercializes organ preservation and